× Unpublished This content is unpublished, click the edit tab and check "Published" on the bottom of the form. 27. 09.15 10:10 Close share menu New results show tumor-targeting activity of KEYTRUDA (Pembrolizumab) in patients with advanced nasopharyngeal carcinoma Source FinanzNachrichten.de Close share menu